Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5360465 | 0.94 | THRB (0.32) | TET2 | |
| SCHEMBL4340451 | 0.92 | THRB (0.35) | — | |
| SCHEMBL5412510 | 0.92 | THRB (0.35) | — | |
| SCHEMBL561206 | 0.86 | TET2 (0.33) | TET2 | |
| SCHEMBL15413473 | 0.81 | — | — | |
| SCHEMBL4313157 | 0.81 | TET2 (0.31) | TET2 | |
| SCHEMBL2806113 | 0.79 | — | — | |
| SCHEMBL10657421 | 0.78 | TET2 (0.32) | TET2 | |
| SCHEMBL1635423 | 0.77 | THRB (0.44) | TET2 | |
| SCHEMBL3850818 | 0.75 | THRB (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4182737-B1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2024-07-03 | — | — | EP | claimed |
| CN-117683423-A | Self-cleaning coating for waterproof coiled material, waterproof coiled material and preparation method thereof | 江苏凯伦建材股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| EP-3359992-B1 | METHOD TO PRODUCE POLYMER CONVERTER FOR CONNECTING OPTICAL FIBRES | WOJSKOWA AKADEMIA TECHNICZNA IM JAROSLAWA DABROWSKIEGO (PL) | 2023-07-12 | — | — | EP | claimed |
| EP-3728339-B1 | COMPOSITION FOR OPHTHALMOLOGICAL PRODUCTS | AMO Ireland (IE) | 2022-07-06 | — | — | EP | claimed |
| EP-2091985-B1 | REVERSIBLE MICELLES AND APPLICATIONS FOR THEIR USE | UNIV LEEDS (GB) | 2013-02-20 | — | — | EP | claimed |
| EP-2021388-B1 | MICHAEL ADDITION ADDUCTS AS ADDITIVES FOR PAPER AND PAPERMAKING | HERCULES INC (US) | 2012-03-21 | — | — | EP | claimed |
| EP-1189622-B1 | ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS | GENZYME CORP (US) | 2007-07-25 | — | — | EP | claimed |
| EP-0915705-B1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GENZYME CORP (US) | 2007-01-10 | — | — | EP | claimed |
| EP-1014999-B1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GENZYME CORP (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1289451-B1 | PROSTHETIC CORNEA | CORNEAL IND (FR) | 2004-12-01 | — | — | EP | claimed |
| EP-0835294-B1 | LIGHT DIFFUSING ADHESIVE | MINNESOTA MINING & MFG (US) | 2003-01-29 | — | — | EP | claimed |
| US-20020114777-A1 | Ionic polymers as anti-infective agents | GELTEX PHARMACEUTICALS, INC. (US) | 2002-08-22 | — | — | US | claimed |
| EP-0981418-B1 | INTRAOCULAR LENS TUMBLING PROCESS USING COATED BEADS | BAUSCH & LOMB SURGICAL INC (US) | 2002-06-26 | — | — | EP | claimed |
| US-6395777-B2 | ORGANONITROGEN POLYMERS | GELTEX PHARMACEUTICALS, INC. | 2002-05-28 | — | — | US | claimed |
| US-20010053794-A1 | Ionic polymers as anti-infective agents | GENZYME CORPORATION | 2001-12-20 | — | — | US | claimed |
| EP-1015000-A1 | ANTIVIRAL POLYMERS COMPRISING ACID FUNCTIONAL AND HYDROPHOBIC GROUPS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-07-05 | — | — | EP | claimed |
| EP-0915705-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-05-19 | — | — | EP | claimed |
| WO-1999015187-A1 | ANTIVIRAL POLYMERS COMPRISING ACID FUNCTIONAL AND HYDROPHOBIC GROUPS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | claimed |
| WO-1997049413-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1997-12-31 | — | — | WO | claimed |
| EP-0036272-B1 | PERMANENT DENTAL RESTORATIVE COMPOSITIONS AND METHODS OF USING THEM | ROHM AND HAAS COMPANY (US) | 1985-01-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010053794-A1 | Ionic polymers as anti-infective agents | PAM, ARG1, PIGS | TET2 1234/4885 |
| US-20020114777-A1 | Ionic polymers as anti-infective agents | PAM, ARG1, PIGS | TET2 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.